Chinese Clinical Practice Guideline for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis

Title: Chinese Clinical Practice Guideline for the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis
Edition: Original
Classification: Standard guideline
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: Healthcare professionals involved in the field of idiopathic pulmonary fibrosis.
Evidence classification method: The Chinese Thoracic Society, Chinese Medical Association and Chinese Association of Chest Physician, Chinese Medical Doctor Association have invited physicians specializing in respiratory medicine and other related fields. Based on recent evidence from evidence-based medicine, they have used the Delphi method to reach a consensus on recommendations and have formulated the Chinese guidelines for the diagnosis and treatment of idiopathic pulmonary fibrosis.
Development unit: Chinese Thoracic Society, Chinese Medical Association; Chinese Association of Chest Physician, Chinese Medical Doctor Association
Registration time: 2024-04-26
Registration number: PREPARE-2024CN587
Purpose of the guideline: The purpose of this guide is to assist clinicians in making informed decisions in the diagnosis and treatment practices of idiopathic pulmonary fibrosis.